1. Stohr K. Influenza: WHO cares. Lancet Infect Dis 2002;2:517.
4. Cox NJ, Subbarao K. Global epidemiology of influenza: past and present. Annu Rev Med 2000;51:407–421.
9. Suarez DL. Evolution of avian influenza viruses. Vet Microbiol 2000;74:15–27.
10. Doyle JD, Chung JR, Kim SS, Gaglani M, Raiyani C, Zimmerman RK,
et al. Interim estimates of 2018-19 seasonal influenza vaccine effectiveness - United States, February 2019. MMWR Morb Mortal Wkly Rep 2019;68:135–139.
11. Rose A, Kissling E, Emborg HD, Larrauri A, McMenamin J, Pozo F,
et al. Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020. Euro Surveill 2020;25:2000153.
12. Chittaganpitch M, Supawat K, Olsen SJ, Waicharoen S, Patthamadilok S, Yingyong T,
et al. Influenza viruses in Thailand: 7 years of sentinel surveillance data, 2004-2010. Influenza Other Respir Viruses 2012;6:276–283.
13. Simmerman JM, Chittaganpitch M, Levy J, Chantra S, Maloney S, Uyeki T,
et al. Incidence, seasonality and mortality associated with influenza pneumonia in Thailand: 2005-2008. PLoS One 2009;4:e7776.
14. Tewawong N, Vichiwattana P, Korkong S, Klinfueng S, Suntronwong N, Thongmee T,
et al. Evolution of the neuraminidase gene of seasonal influenza A and B viruses in Thailand between 2010 and 2015. PLoS One 2017;12:e0175655.
15. Tewawong N, Suntronwong N, Korkong S, Theamboonlers A, Vongpunsawad S, Poovorawan Y. Evidence for influenza B virus lineage shifts and reassortants circulating in Thailand in 2014-2016. Infect Genet Evol 2017;47:35–40.
17. Suntronwong N, Klinfueng S, Vichiwattana P, Korkong S, Thongmee T, Vongpunsawad S,
et al. Genetic and antigenic divergence in the influenza A(H3N2) virus circulating between 2016 and 2017 in Thailand. PLoS One 2017;12:e0189511.
18. Imai K, Tamura K, Tanigaki T, Takizawa M, Nakayama E, Taniguchi T,
et al. Whole genome sequencing of influenza A and B viruses with the MinION sequencer in the clinical setting: a pilot study. Front Microbiol 2018;9:2748.
20. Suwannakarn K, Payungporn S, Chieochansin T, Samransamruajkit R, Amonsin A, Songserm T,
et al. Typing (A/B) and subtyping (H1/H3/H5) of influenza A viruses by multiplex real-time RT-PCR assays. J Virol Methods 2008;152:25–31.
21. Tewawong N, Chansaenroj J, Klinfueng S, Vichiwattana P, Korkong S, Thongmee T,
et al. Lineage-specific detection of influenza B virus using real-time polymerase chain reaction with melting curve analysis. Arch Virol 2016;161:1425–1435.
26. Korsun NS, Angelova SG, Trifonova IT, Georgieva IL, Tzotcheva IS, Mileva SD,
et al. Predominance of influenza B/Yamagata lineage viruses in Bulgaria during the 2017/2018 season. Epidemiol Infect 2019;147:e76.
27. Hall T. BioEdit: an important software for molecular biology. GERF Bull Biosci 2011;2:60–61.
29. Kofler R, Orozco-terWengel P, De Maio N, Pandey RV, Nolte V, Futschik A,
et al. PoPoolation: a toolbox for population genetic analysis of next generation sequencing data from pooled individuals. PLoS One 2011;6:e15925.
32. Zhao J, Liu J, Vemula SV, Lin C, Tan J, Ragupathy V,
et al. Sensitive detection and simultaneous discrimination of influenza A and B viruses in nasopharyngeal swabs in a single assay using next-generation sequencing-based diagnostics. PLoS One 2016;11:e0163175.
33. Kampmann ML, Fordyce SL, Avila-Arcos MC, Rasmussen M, Willerslev E, Nielsen LP,
et al. A simple method for the parallel deep sequencing of full influenza A genomes. J Virol Methods 2011;178:243–248.
34. Zhao XN, Zhang HJ, Li D, Zhou JN, Chen YY, Sun YH,
et al. Whole-genome sequencing reveals origin and evolution of influenza A(H1N1)pdm09 viruses in Lincang, China, from 2014 to 2018. PLoS One 2020;15:e0234869.
37. Van Poelvoorde LAE, Saelens X, Thomas I, Roosens NH. Next-generation sequencing: an eye-opener for the surveillance of antiviral resistance in influenza. Trends Biotechnol 2020;38:360–367.
38. Deng YM, Spirason N, Iannello P, Jelley L, Lau H, Barr IG. A simplified Sanger sequencing method for full genome sequencing of multiple subtypes of human influenza A viruses. J Clin Virol 2015;68:43–48.
41. Rondy M, Kissling E, Emborg HD, Gherasim A, Pebody R, Trebbien R,
et al. Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies. Euro Surveill 2018;23:18–00086.
42. Flannery B, Chung JR, Belongia EA, McLean HQ, Gaglani M, Murthy K,
et al. Interim estimates of 2017-18 seasonal influenza vaccine effectiveness - United States, February 2018. MMWR Morb Mortal Wkly Rep 2018;67:180–185.
46. Belanov SS, Bychkov D, Benner C, Ripatti S, Ojala T, Kankainen M,
et al. Genome-wide analysis of evolutionary markers of human influenza A(H1N1)pdm09 and A(H3N2) viruses may guide selection of vaccine strain candidates. Genome Biol Evol 2015;7:3472–3483.
49. Ramos AP, Herrera BA, Ramirez OV, Garcia AA, Jimenez MM, Valdes CS,
et al. Molecular and phylogenetic analysis of influenza A H1N1 pandemic viruses in Cuba, May 2009 to August 2010. Int J Infect Dis 2013;17:e565–e567.
51. Jimenez-Jorge S, Pozo F, de Mateo S, Delgado-Sanz C, Casas I, Garcia-Cenoz M,
et al. Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study. Euro Surveill 2014;19:20727.
53. Cheng AC, Subbarao K. Epidemiological data on the effectiveness of influenza vaccine: another piece of the puzzle. J Infect Dis 2018;218:176–178.
55. Al Khatib HA, Al Maslamani MA, Coyle PV, Thompson IR, Farag EA, Al Thani AA,
et al. Inter- versus intra-host sequence diversity of pH1N1 and associated clinical outcomes. Microorganisms 2020;8:133.
58. Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. Mol Cell 1998;1:991–1000.
60. Mao H, Sun Y, Chen Y, Lou X, Yu Z, Wang X,
et al. Co-circulation of influenza A(H1N1), A(H3N2), B(Yamagata) and B(Victoria) during the 2017-2018 influenza season in Zhejiang Province, China. Epidemiol Infect 2020;148:e296.
61. Boonnak K, Mansanguan C, Schuerch D, Boonyuen U, Lerdsamran H, Jiamsomboon K,
et al. Molecular characterization of seasonal influenza A and B from hospitalized patients in Thailand in 2018-2019. Viruses 2021;13:977.
65. Takashita E, Daniels RS, Fujisaki S, Gregory V, Gubareva LV, Huang W,
et al. Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017-2018. Antiviral Res 2020;175:104718.